Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones

C. Volonté, M. T. Ciotti, N. D'Ambrosi, B. Lockhart, M. Spedding

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

In previous studies (Volonte and Merlo, 1996. J. Neurosci. Res. 45, 183-193) basilen blue was shown to be a P2 receptor antagonist which abrogated glutamate-mediated cytotoxicity in cerebellar neurones in primary culture. Our work has now been extended to evaluate the neuroprotective action of the compound in additional neuronal systems, as well as in a different paradigm of cell death. We show that basilen blue prevents L-glutamate-mediated neurotoxicity in rat cerebellar (90-100% inhibition), cortical (60-70%) and hippocampal (50%) neurones. Similarly, glutamate-dependent progressive darkening of cell bodies, loss of phase-brightness and rapid cellular swelling are inhibited. Basilen blue is significantly less toxic and more effective at blocking L-glutamate toxicity in mixed cortical/glial cultures, compared to its structural analogue cibacron blue. Moreover, its neuroprotective effect is correlated with the time of incubation with granule neurones. Other purinoceptor ligands, including 2,2'-pyridylisatogen, but not pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid 4-sodium, are also effective in preventing glutamate toxicity. Furthermore, basilen blue prevents serum deprivation- and low potassium-induced apoptotic cell death in cerebellar granule neurones. In summary, our data extend and reinforce the possibility of a potential therapeutic use of P2 receptor modulators as neuroprotective agents for the central nervous system. Copyright (C) 1999 Elsevier Science Ltd.

Original languageEnglish
Pages (from-to)1335-1342
Number of pages8
JournalNeuropharmacology
Volume38
Issue number9
DOIs
Publication statusPublished - Sep 1999

Fingerprint

Cibacron Blue F 3GA
Neuroprotective Agents
Glutamic Acid
Neurons
Cell Death
Purinergic Receptors
Poisons
Therapeutic Uses
Neuroglia
Potassium
Central Nervous System
Sodium
Ligands
Serum

Keywords

  • Basilen blue
  • Excitotoxicity
  • Neuroprotection
  • Purinoceptors
  • Pyridylisatogen

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones. / Volonté, C.; Ciotti, M. T.; D'Ambrosi, N.; Lockhart, B.; Spedding, M.

In: Neuropharmacology, Vol. 38, No. 9, 09.1999, p. 1335-1342.

Research output: Contribution to journalArticle

Volonté, C. ; Ciotti, M. T. ; D'Ambrosi, N. ; Lockhart, B. ; Spedding, M. / Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones. In: Neuropharmacology. 1999 ; Vol. 38, No. 9. pp. 1335-1342.
@article{6b15906a7df1461f9fa0cb6482a2b78f,
title = "Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones",
abstract = "In previous studies (Volonte and Merlo, 1996. J. Neurosci. Res. 45, 183-193) basilen blue was shown to be a P2 receptor antagonist which abrogated glutamate-mediated cytotoxicity in cerebellar neurones in primary culture. Our work has now been extended to evaluate the neuroprotective action of the compound in additional neuronal systems, as well as in a different paradigm of cell death. We show that basilen blue prevents L-glutamate-mediated neurotoxicity in rat cerebellar (90-100{\%} inhibition), cortical (60-70{\%}) and hippocampal (50{\%}) neurones. Similarly, glutamate-dependent progressive darkening of cell bodies, loss of phase-brightness and rapid cellular swelling are inhibited. Basilen blue is significantly less toxic and more effective at blocking L-glutamate toxicity in mixed cortical/glial cultures, compared to its structural analogue cibacron blue. Moreover, its neuroprotective effect is correlated with the time of incubation with granule neurones. Other purinoceptor ligands, including 2,2'-pyridylisatogen, but not pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid 4-sodium, are also effective in preventing glutamate toxicity. Furthermore, basilen blue prevents serum deprivation- and low potassium-induced apoptotic cell death in cerebellar granule neurones. In summary, our data extend and reinforce the possibility of a potential therapeutic use of P2 receptor modulators as neuroprotective agents for the central nervous system. Copyright (C) 1999 Elsevier Science Ltd.",
keywords = "Basilen blue, Excitotoxicity, Neuroprotection, Purinoceptors, Pyridylisatogen",
author = "C. Volont{\'e} and Ciotti, {M. T.} and N. D'Ambrosi and B. Lockhart and M. Spedding",
year = "1999",
month = "9",
doi = "10.1016/S0028-3908(99)00034-9",
language = "English",
volume = "38",
pages = "1335--1342",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones

AU - Volonté, C.

AU - Ciotti, M. T.

AU - D'Ambrosi, N.

AU - Lockhart, B.

AU - Spedding, M.

PY - 1999/9

Y1 - 1999/9

N2 - In previous studies (Volonte and Merlo, 1996. J. Neurosci. Res. 45, 183-193) basilen blue was shown to be a P2 receptor antagonist which abrogated glutamate-mediated cytotoxicity in cerebellar neurones in primary culture. Our work has now been extended to evaluate the neuroprotective action of the compound in additional neuronal systems, as well as in a different paradigm of cell death. We show that basilen blue prevents L-glutamate-mediated neurotoxicity in rat cerebellar (90-100% inhibition), cortical (60-70%) and hippocampal (50%) neurones. Similarly, glutamate-dependent progressive darkening of cell bodies, loss of phase-brightness and rapid cellular swelling are inhibited. Basilen blue is significantly less toxic and more effective at blocking L-glutamate toxicity in mixed cortical/glial cultures, compared to its structural analogue cibacron blue. Moreover, its neuroprotective effect is correlated with the time of incubation with granule neurones. Other purinoceptor ligands, including 2,2'-pyridylisatogen, but not pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid 4-sodium, are also effective in preventing glutamate toxicity. Furthermore, basilen blue prevents serum deprivation- and low potassium-induced apoptotic cell death in cerebellar granule neurones. In summary, our data extend and reinforce the possibility of a potential therapeutic use of P2 receptor modulators as neuroprotective agents for the central nervous system. Copyright (C) 1999 Elsevier Science Ltd.

AB - In previous studies (Volonte and Merlo, 1996. J. Neurosci. Res. 45, 183-193) basilen blue was shown to be a P2 receptor antagonist which abrogated glutamate-mediated cytotoxicity in cerebellar neurones in primary culture. Our work has now been extended to evaluate the neuroprotective action of the compound in additional neuronal systems, as well as in a different paradigm of cell death. We show that basilen blue prevents L-glutamate-mediated neurotoxicity in rat cerebellar (90-100% inhibition), cortical (60-70%) and hippocampal (50%) neurones. Similarly, glutamate-dependent progressive darkening of cell bodies, loss of phase-brightness and rapid cellular swelling are inhibited. Basilen blue is significantly less toxic and more effective at blocking L-glutamate toxicity in mixed cortical/glial cultures, compared to its structural analogue cibacron blue. Moreover, its neuroprotective effect is correlated with the time of incubation with granule neurones. Other purinoceptor ligands, including 2,2'-pyridylisatogen, but not pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid 4-sodium, are also effective in preventing glutamate toxicity. Furthermore, basilen blue prevents serum deprivation- and low potassium-induced apoptotic cell death in cerebellar granule neurones. In summary, our data extend and reinforce the possibility of a potential therapeutic use of P2 receptor modulators as neuroprotective agents for the central nervous system. Copyright (C) 1999 Elsevier Science Ltd.

KW - Basilen blue

KW - Excitotoxicity

KW - Neuroprotection

KW - Purinoceptors

KW - Pyridylisatogen

UR - http://www.scopus.com/inward/record.url?scp=0032791867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032791867&partnerID=8YFLogxK

U2 - 10.1016/S0028-3908(99)00034-9

DO - 10.1016/S0028-3908(99)00034-9

M3 - Article

C2 - 10471087

AN - SCOPUS:0032791867

VL - 38

SP - 1335

EP - 1342

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 9

ER -